logo
logo

Redwoods Acquisition completes PIPE agreement to support approved ANEW Medical deal

Redwoods Acquisition completes PIPE agreement to support approved ANEW Medical deal

06/14/24, 1:08 PM
Location
https://purecatamphetamine.github.io/country-flag-icons/3x2/GB.svglondon
https://purecatamphetamine.github.io/country-flag-icons/3x2/US.svgomaha
Industry
biotechnology
health care
Redwoods Acquisition has finalized a PIPE agreement with Meteora Capital Partners and affiliates to purchase up to 1 million shares, securing funds to support the approved merger with ANEW Medical. The merger agreement originally included terms for ANEW to receive up to $60 million in stock, with a focus on developing disruptive therapies for neurodegenerative diseases.

Company Info

Company
JVSPAC Acquisition Corporation
Location
London, England, United Kingdom
Company info
JVSPAC Acquisition Corporation is a Nasdaq-listed acquisition company focused on completing a business combination with innovative and promising companies. The corporation seeks to identify a target business with significant growth potential and a management team capable of delivering value to its shareholders.
G2 High Performer Badge

Unlock Strategic Intelligence with Fundz

Access real-time funding updates, strategic shifts with FundzWatch™, exclusive Family Offices, and more — helping you close deals and seize opportunities faster.

Trusted by sales, BD, and investment teams at Oracle, HubSpot, Affinity, and more.

Related people

MH

SH

AH

RH

BH

Sign up to get related executive contact information

Trends

RaisedGrowth

The data in the raised column shows reported funding for this location/industry over last 90 days.

The data in the growth column indicates the % increase or decrease of the last 90 days vs. the previous 90 days.

Please note: one or more large fundings, especially for a location/industry that doesn't historically receive much funding, can have a significant impact on the increase or decrease percentage.

biotechnology
$9.9 B-13.2%
health care
$8.3 B-27.1%